Showing 1,281 - 1,300 results of 4,368 for search 'significant clinical decrease', query time: 0.32s Refine Results
  1. 1281

    S1 Dataset - by Riham Saud Alhazmy (19697677)

    Published 2024
    “…</p><p>Results</p><p>The mean HbA1c level decreased from 8.61 ± 1.70 to 7.92 ± 1.60 after implementing the WhatsApp group instructions; the values showed a significant difference (t-value = 5.107 and <i>P</i>-value < 0.001). …”
  2. 1282

    Particepant recruitment flowchart. by Riham Saud Alhazmy (19697677)

    Published 2024
    “…</p><p>Results</p><p>The mean HbA1c level decreased from 8.61 ± 1.70 to 7.92 ± 1.60 after implementing the WhatsApp group instructions; the values showed a significant difference (t-value = 5.107 and <i>P</i>-value < 0.001). …”
  3. 1283

    Flow of participants through the study. by Sedighe Esmaeilzadeh (21100668)

    Published 2025
    “…Furthermore, melatonin significantly decreased sleep latency, exhibiting a large effect size, and contributed to a medium reduction in the use of sleep medications. …”
  4. 1284

    Demographic Characteristics of Participants. by Sedighe Esmaeilzadeh (21100668)

    Published 2025
    “…Furthermore, melatonin significantly decreased sleep latency, exhibiting a large effect size, and contributed to a medium reduction in the use of sleep medications. …”
  5. 1285

    Table 1_The efficacy of infliximab combined with partial enteral nutrition in the treatment of Crohn’s disease: a cohort study.docx by Chen Huang (202847)

    Published 2025
    “…</p>Results<p>Among the 176 included patients, 99 (56%) were in the IFX monotherapy group, and 77 (44%) were in the IFX + PEN group. A significantly higher proportion of patients in the IFX + PEN group achieved clinical response (defined as a CDAI decrease ≥70 points) compared to those in the IFX group at 14 weeks (87.01% vs. 74.75%, p = 0.043), as well as a higher proportion achieving endoscopic remission at 54 weeks (84.42% vs. 65.66%, p = 0.005). …”
  6. 1286
  7. 1287
  8. 1288
  9. 1289
  10. 1290
  11. 1291
  12. 1292
  13. 1293
  14. 1294
  15. 1295
  16. 1296
  17. 1297
  18. 1298

    Supplementary Material for: Clinical and brain MRI characteristics of patients with Anti-N-Methyl-D-Aspartate Receptor Encephalitis: A 10-Year Retrospective Study by figshare admin karger (2628495)

    Published 2025
    “…Although 91% of patients with mRS >2 before treatment, statistically significant decreased mRS were observed after treatment (mRS: 3.50 ± 0.94 vs mRS: 1.91 ± 1.53, P < 0.001). …”
  19. 1299
  20. 1300